Fundraising Fox
Kythera Labs
Franklin, US · Founded 2023 · Delaware corporation · 37 employees on LinkedIn · 2 known investors
Find your way into Kythera Labs
Each arrow is one introduction. Sign up to fill in the first one.
469 people can intro you to Rob
Ask James Orsillo to introduce you to Rob Grant
You →James · together at Evariant →Rob
350 people can intro you to Glynn
Ask Jamie Chen to introduce you to Glynn Dennis
You →Jamie · together at SAIC →Glynn
263 people can intro you to Russ
Ask Sam Okafor to introduce you to Russ Sacks
You →Sam · together at Medsolutions →Russ
- Matt Ryan259 people can intro you
- Jeremy Ellis23 people can intro you
Sign up to find every way you can get introduced to Kythera Labs
- Your email: who you already know at Kythera Labs, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kythera Labs team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kythera Labs builds data technology and analytics products for the healthcare and life sciences industries, focused on processing and analyzing large-scale healthcare and real-world data. Its platform supports market analysis, operational decision-making, and BioPharma research for healthcare organizations.
Founders & leadership
Kythera Labs was founded in 2023 by Matt Ryan.
MR
Matt RyanChief Technology OfficerChief Technology Officer at Kythera Labs, an analytics platform for healthcare and life sciences organizations. Ryan has background in information technology leadership across multiple industries with focus on large-scale data analytics in healthcare.
RG
Rob GrantChief Commercial OfficerHe has led sales, strategy, and marketing teams across multiple companies and industries.
GD
Glynn DennisChief Science OfficerGlynn Dennis is Chief Science Officer at Kythera Labs, which develops data analytics platforms for healthcare and life sciences organizations. He focuses on building AI systems to analyze real-world healthcare data across patients, providers, and disease domains.
RS
Russ SacksEVP, Innovation and Data ScienceRuss Sacks held roles ranging from operations at early-stage startups to management at a Fortune 500 company, and has worked as a consultant on data science and operations research projects. He brings expertise in data science, operations research, continuous improvement, and software development.
JE
Jeremy EllisEVP, Business DevelopmentJeremy Ellis is EVP of Business Development at Kythera Labs, which builds data analytics products for healthcare and life sciences organizations. He brings over a decade of experience in technology, healthcare, and marketing roles.
AP
JG
Jay GalbreathNamed on SEC filing
Investors · 2
BIP VenturesreportedAtlanta
How we know: funding news · Not right? Tell us
CIBCreportedToronto · $1.5M – $29.2M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20.9M disclosed across 2 rounds · 2023–2024
▶$9.2MraisedMay 2024 · 6 investors · Other TechnologyRule 506(b)
▶$9.2MraisedMay 2024 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Rob DraughonDirector
- Jeff McDonaldExecutive Officer, Director
- Jay GalbreathExecutive Officer
- Austin PooleDirector
- Jeff KleinDirector
- Ryan LeurckExecutive Officer, Director
- Offering amount
- $9.2M
- Amount sold
- $9.2M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$11.7MraisedMay 2023 · 3 investors · Other TechnologyRule 506(b)
▶$11.7MraisedMay 2023 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Austin PooleDirector, Promoter
- Jay GalbreathExecutive Officer, Promoter
- Ryan LeurckExecutive Officer, Director, Promoter
- Jeff McDonaldExecutive Officer, Director, Promoter
- Offering amount
- $13.5M
- Amount sold
- $11.7M
- Minimum investment
- $25K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 9
RayTheraA biopharmaceutical company developing therapies for neurology, immunology, and rare diseases. The page describes work focused on treating hard-to-treat conditions.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
AltaThera PharmaceuticalsAltaThera develops intravenous antiarrhythmic therapies for treating cardiac conditions including atrial fibrillation and ventricular tachycardia. The company's lead product, Sotalol IV, enables faster patient assessment and potential outpatient discharge compared to oral alternatives.
Kymera TherapeuticsKymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.
Kite PharmaKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
InnovaccerInnovaccer offers Provider Copilot, an AI assistant that automates clinical documentation, pre-visit prep, medical scribing, and prior authorization workflows for healthcare providers and care teams. The tool integrates into clinical workflows to check patient coverage, verify charts against payer rules, and submit prior auth packets electronically, by portal, or fax.
Definitive HealthcareDefinitive Healthcare delivers market intelligence and data analytics on healthcare organizations, clinicians, and consumers, serving life sciences companies, healthcare providers, and other industries that interact with healthcare. The company provides data consolidation, analytics services, and digital advertising activation capabilities to help customers make informed decisions in the healthcare market.
DatavantDatavant Connect is a data connectivity platform that enables healthcare and life sciences organizations to share and link datasets while maintaining privacy compliance through tokenization technology. The platform addresses the need to balance data utility with regulatory requirements like HIPAA de-identification standards.
KayoTheraKayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology. The company is led by an experienced management team supported by scientific and clinical advisory boards.
Companies working in the same space as Kythera Labs.
In the news
Frequently asked questions
- What does Kythera Labs do?
- Kythera Labs builds data technology and analytics products for the healthcare and life sciences industries, focused on processing and analyzing large-scale healthcare and real-world data. Its platform supports market analysis, operational decision-making, and BioPharma research for healthcare organizations.
- Who founded Kythera Labs?
- Kythera Labs was founded by Matt Ryan in 2023.
- Who are Kythera Labs's investors?
- Kythera Labs's investors include BIP Ventures, CIBC.
- How much funding has Kythera Labs raised?
- Kythera Labs has disclosed $20.9M raised across 2 rounds.
- Where is Kythera Labs headquartered?
- Kythera Labs is headquartered in Franklin, US.